Renaissance Technologies’s Turnstone Biologics TSBX Stock Holding History

Renaissance Technologies’s Portfolio TSBX Stock Details TSBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-47,100	Closed	-$16.9K	–	3933
2025 Q2	$16.9K	Buy	47,100 +6,900	+17%	+$2.42K	﹤0.01%	3481
2025 Q1	$16.5K	Buy	40,200 +16,300	+68%	+$6.94K	﹤0.01%	3369
2024 Q4	$11.9K	Buy	+23,900	New	+$11.8K	﹤0.01%	3513

Renaissance Technologies's TSBX Position: Q3 2025 in Review

Renaissance Technologies sold out of Turnstone Biologics (TSBX) in Q3 2025, closing a stake of 47,100 shares — an estimated $16.9K sold.

Renaissance Technologies first reported a position in TSBX in Q4 2024 and held it in 3 quarters. The position peaked at $16.9K in Q2 2025. 1 fund tracked by Wall St. Rank holds TSBX as of Q3 2025.

Renaissance Technologies reported no remaining Turnstone Biologics position as of Q3 2025 after selling out during the quarter.
Renaissance Technologies sold 47,100 Turnstone Biologics shares in Q3 2025, an estimated $16.9K.
Renaissance Technologies first reported a position in Turnstone Biologics in Q4 2024 and held it in 3 quarters.
Renaissance Technologies's Turnstone Biologics position peaked at $16.9K in Q2 2025.
1 fund tracked by Wall St. Rank held Turnstone Biologics as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.